Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Neuropsychotherapeutics and stimulants

US prescribing trends

    • 7 Accesses

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Neuropsychotherapeutics and stimulants. Pharmacoecon. Outcomes News 151, 10 (1998). https://doi.org/10.1007/BF03277429

    Download citation

    Keywords

    • Methylphenidate
    • American Medical Association
    • Selective Serotonin Reuptake Inhibitor
    • Psychotropic Medication
    • Physician Visit